Insider trades

Abernethy Matt

Abernethy Matt made 0 buys and 1 sale on the open market in the last 12 months at Neurocrine Biosciences, Inc. Each trade with the role, price and filing.

DateCompanyTradeSharesPrice
Sep 14, 2026Neurocrine Biosciences, Inc.Sale2,311US$157